why choose us

First received: January 22, 2025

Clinical Trial: A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Autoimmune Disease

Study Type: INTERVENTIONAL


Official Title: A Single-center, Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Subcutane

Brief Summary: This study is designed to evaluate the safety, tolerability, PK and PD of GenSci120 in a randomized, double-blind, placebo-controlled trial involving healthy adult participants.

Read more